Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6.
Akash VirupakshaiahCarson E MoseleySteven EliceguiLee M GerwitzCollin M SpencerElizabeth GeorgeMaulik P ShahBruce Anthony Campbell CreeEmmanuelle WaubantScott S ZamvilPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
Acute disseminated encephalomyelitis (ADEM) is one characteristic manifestation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). A previously healthy man presented with retro-orbital headache and urinary retention 14 days after Tdap vaccination. Brain and spine MRI suggested a CNS demyelinating process. Despite treatment with IV steroids, he deteriorated, manifesting hemiparesis and later impaired consciousness, requiring intubation. A repeat brain MRI demonstrated new bilateral supratentorial lesions associated with venous sinus thrombosis, hemorrhage, and midline shift. Anti-MOG antibody was present at a high titer. CSF IL-6 protein was >2,000 times above the upper limits of normal. He improved after plasma exchange, then began monthly treatment alone with anti-IL-6 receptor antibody, tocilizumab, and has remained stable. This case highlights how adult-onset MOGAD, like childhood ADEM, can rapidly become life-threatening. The markedly elevated CSF IL-6 observed here supports consideration for evaluating CSF cytokines more broadly in patients with acute MOGAD.
Keyphrases
- magnetic resonance imaging
- white matter
- resting state
- contrast enhanced
- rheumatoid arthritis
- cerebrospinal fluid
- pulmonary embolism
- computed tomography
- cardiac arrest
- liver failure
- functional connectivity
- systemic lupus erythematosus
- drug induced
- magnetic resonance
- young adults
- multiple sclerosis
- rheumatoid arthritis patients
- brain injury
- replacement therapy
- smoking cessation